Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 24, 2000

View Archived Issues

deCODE identifies schizophrenia gene

American Home Products and Aventis renegotiate agreement

Update on Pharmacia's ocular medications

Prilosec receives positive recommendation for OTC status

Pharmacokinetics, pharmacodynamics and safety of i.v. RGD-891 studied in healthy volunteers

PSC-833 produces marked but incomplete reversal of MDR in the presence of human serum

Design of AMPA-selective compounds with a triazoloquinoxaline-2-carboxylate framework

SRL-172 has positive effects on response rate, survival and quality of life in NSCLC

CS-834: oral absorption kinetics in rats reported at recent scientific meeting

HIV protease inhibitor Agenerase approved in E.U.

Serono to develop Axonyx's amyloid- and prion-inhibitory peptides

Once-weekly Fosamax approved by FDA

U.S. launch of Innohep as DVT therapy announced at San Francisco meeting

Combination represents new strategy for treatment-resistant schizophrenia

First oral chemotherapy for colorectal cancer recommended for approval in Europe

Retinoid antagonists and their use described in recent patent by Roche

AHP's novel imide derivatives useful for serotonergic neuron-related conditions

New Y5 receptor antagonists claimed for eating disorders, etc. by Synaptic

NIH presents novel HIV-1 integrase inhibitors

Selective M3 receptor antagonists and their use described by Japanese scientists

U. of Mississippi prepares novel series of PPARgamma-activating agents

Recent patent covers Medicure's new pyridoxal analogues

Novel meiosis inhibitors emerge from Akzo Nobel R&D

Therapeutic products agreement finalized by Medarex and IDM

ZymoGenetics launched as independent biotechnology company

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...